Mesoblast Limited (MEOBF) Financials

MEOBF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 773.1 million 204.7 million
March 31, 2026 773.1 million 204.7 million
Dec. 31, 2025 782.3 million 207.6 million
Sept. 30, 2025 782.3 million 207.6 million

MEOBF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -6.9 million 2.9 million
March 31, 2026 -4.5 million ?
Dec. 31, 2025 -15.7 million ?
Sept. 30, 2025 -15.3 million ?

MEOBF Net Income

No data available :(

MEOBF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 102.9 million 108.6 million 8.1 million
March 31, 2026 102.9 million 108.6 million 8.1 million
Dec. 31, 2025 129.6 million 60.1 million 8.3 million
Sept. 30, 2025 130.0 million 60.1 million 8.3 million

MEOBF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 1.3 billion
March 31, 2026 1.3 billion
Dec. 31, 2025 1.3 billion
Sept. 30, 2025 1.3 billion

MEOBF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 205500 25.7 million 14.4 million -
March 31, 2026 352000 25.7 million 14.4 million -
Dec. 31, 2025 133000 23.1 million 14.3 million -
Sept. 30, 2025 349000 23.1 million 14.3 million -

MEOBF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 37.0 million -49.1 million
March 31, 2026 34.5 million 14.9 million
Dec. 31, 2025 25.7 million 26.9 million
Sept. 30, 2025 25.7 million 26.9 million

MEOBF

Price: $1.32

52 week price:
1.14
2.59

Earnings Per Share: -0.04 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 1.8 billion

Links: